Aridis Pharmaceuticals, Inc. Gains 114.81%

Wed, May 31, 2023 at 07:47 PM
Aridis Pharmaceuticals, Inc. Gains 114.81%

Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ) jumped higher at $0.4, representing a gain of 114.8%. On Wed, May 31, 2023, ARDS:NASDAQ touched a New 2-Week High of $0.4. The stock appeared on our News Catalysts scanner on Wed, May 31, 2023 at 08:23 AM in the 'AGREEMENT' category. From Wed, May 17, 2023, the stock recorded 22.22% Up Days and 30.00% Green Days

The stock spiked on Wed, May 31, 2023 at $0.54 with a volume of 179M+.

About Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ)

Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.